Advantage Autism And Therapy Services, Llc | |
2111 155th St Atalissa IA 52720-9751 | |
(563) 299-0886 | |
Not Available |
Full Name | Advantage Autism And Therapy Services, Llc |
---|---|
Speciality | Behavior Analyst |
Location | 2111 155th St, Atalissa, Iowa |
Authorized Official Name and Position | Brianna M Harvey (OWNER) |
Authorized Official Contact | 5632990886 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Advantage Autism And Therapy Services, Llc 2111 155th St Atalissa IA 52720-9751 Ph: (563) 299-0886 | Advantage Autism And Therapy Services, Llc 2111 155th St Atalissa IA 52720-9751 Ph: (563) 299-0886 |
NPI Number | 1497229348 |
---|---|
Provider Enumeration Date | 01/14/2019 |
Last Update Date | 01/14/2019 |
Identifier | Type | State | Issuer |
---|---|---|---|
1497229348 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
News Archive
Aperio Technologies, Inc. announced today that the United States Patent and Trademark Office has issued the company patent No. 7,428,324 entitled "System and Method for Data Management in a Linear-array based Microscope Slide Scanner."
A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC).The cost effectiveness analysis concluded that CTC or virtual colonoscopy is not cost effective compared with colonoscopy if reimbursed at the same rate as colonoscopy
Pregnant women exposed to higher levels of the commonly used chemical bisphenol A (BPA) are more likely to have children who suffer with wheezing and poorer lung function, according to research presented at the European Respiratory Society International Congress.
It is common for critically ill patients on life support to develop delirium, a form of acute brain failure for which no effective treatment is known.
The level at which red blood cells are transfused, a common treatment in clinical practice, is often deliberated among physicians. Guidelines for blood transfusion levels were only recently issued in March 2012 diminishing some of the debate. Today, in a new section called JAMA Clinical Evidence Synopsis, the Journal of the American Medical Association (JAMA), published a summary of the systematic review of the 19 clinical trials that compare higher versus lower hemoglobin thresholds in red blood cell transfusion.
› Verified 1 days ago